The Novel Cyclin-Dependent Kinase Inhibitor Dinaciclib (SCH727965) Promotes Apoptosis and Abrogates Microenvironmental Cytokine Protection in Chronic Lymphocytic Leukemia Cells

The cyclin dependent kinase (CDK) inhibitor flavopiridol has demonstrated promising clinical results in relapsed CLL patients leading to efforts to develop improved CDK inhibitors. Dinaciclib (SCH727965) is a pan-CDK inhibitor, derived from a detailed screen in ovarian xenograft mouse models for the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Johnson, Amy J., Yeh, Yuh-Ying, Smith, Lisa L., Wagner, Amy J., Hessler, Joshua, Gupta, Sneha, Flynn, Joseph, Jones, Jeffrey, Zhang, Xiaoli, Bannerji, Rajat, Grever, Michael R., Byrd, John C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3645353/
https://ncbi.nlm.nih.gov/pubmed/22791353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.144
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia